Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Share Repurchase Authorization Remaining by Quarter
Share Repurchase Authorization Remaining (millions of shares) (M)
Stryker Share Repurchase Authorization Remaining: 33M in Q3 2026, down 96.8% from a year earlier. That is the lowest of the 24 quarters on record here.
Latest, Q3 2026
33
Period ended Sep 30, 2026
Change on a year earlier
-96.8%
1,033 in Q3 2025
History
24 quarters
Since Q4 2017
Sources
24
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 10-Q Part II Item 2 & Form 10-K Item 5.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Share Repurchase Authorization Remaining (M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ops-bb-auth-rem
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.